Elizabeth Slow

4.1k total citations · 2 hit papers
35 papers, 2.9k citations indexed

About

Elizabeth Slow is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Elizabeth Slow has authored 35 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 20 papers in Cellular and Molecular Neuroscience and 14 papers in Molecular Biology. Recurrent topics in Elizabeth Slow's work include Genetic Neurodegenerative Diseases (19 papers), Neurological disorders and treatments (16 papers) and Parkinson's Disease Mechanisms and Treatments (14 papers). Elizabeth Slow is often cited by papers focused on Genetic Neurodegenerative Diseases (19 papers), Neurological disorders and treatments (16 papers) and Parkinson's Disease Mechanisms and Treatments (14 papers). Elizabeth Slow collaborates with scholars based in Canada, United States and United Kingdom. Elizabeth Slow's co-authors include Michael R. Hayden, Blair R. Leavitt, Rona K. Graham, Jacqueline Pearson, Jeremy M. Van Raamsdonk, Ge Lu, Zoe Murphy, Nagat Bissada, Ilya Bezprozvanny and Yu Deng and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Elizabeth Slow

33 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease

2003 640 citations Elizabeth Slow Human Molecular Genetics profile →
Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin

2006 505 citations Rona K. Graham, Yu Deng et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Slow Canada	17	2.3k	2.1k	1.1k	183	175	35	2.9k
Milena Cannella Italy	29	1.5k 0.7×	1.3k 0.6×	1.1k 1.0×	270 1.5×	110 0.6×	60	2.4k
Esther Pérez‐Navarro Spain	33	2.0k 0.8×	1.6k 0.7×	606 0.6×	235 1.3×	133 0.8×	90	2.8k
Albert Giralt Spain	31	1.6k 0.7×	1.7k 0.8×	672 0.6×	447 2.4×	149 0.9×	73	2.8k
Liliana Menalled United States	19	2.0k 0.8×	1.5k 0.7×	1.0k 0.9×	110 0.6×	94 0.5×	28	2.3k
Gloria J. Klapstein United States	15	1.9k 0.8×	1.3k 0.6×	960 0.9×	259 1.4×	127 0.7×	18	2.5k
Jean‐Paul Vonsattel United States	13	3.3k 1.4×	2.7k 1.3×	1.9k 1.7×	413 2.3×	260 1.5×	20	4.4k
Austen J. Milnerwood Canada	29	2.0k 0.9×	1.5k 0.7×	1.5k 1.4×	561 3.1×	405 2.3×	46	3.1k
Kay Seidel Germany	30	1.7k 0.8×	1.5k 0.7×	1.1k 1.0×	392 2.1×	181 1.0×	50	2.7k
M.‐F. Chesselet United States	24	1.8k 0.8×	1.1k 0.5×	530 0.5×	206 1.1×	81 0.5×	31	2.4k
J.-P. G. Vonsattel United States	16	3.2k 1.4×	2.6k 1.3×	2.0k 1.8×	486 2.7×	307 1.8×	22	4.4k

Countries citing papers authored by Elizabeth Slow

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Slow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Slow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Slow more than expected).

Fields of papers citing papers by Elizabeth Slow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Slow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Slow. The network helps show where Elizabeth Slow may publish in the future.

Co-authorship network of co-authors of Elizabeth Slow

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Slow. A scholar is included among the top collaborators of Elizabeth Slow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Slow. Elizabeth Slow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eissazade, Negin, et al.. (2026). Oculogyric crisis induced by high-dose apomorphine in a patient with advanced Parkinson's disease. Parkinsonism & Related Disorders. 144. 108186–108186.

Zhou, Lily, Sarah Furtado, Verónica Bruno, et al.. (2023). Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada. Movement Disorders Clinical Practice. 10(3). 440–451. 8 indexed citations

Youn, Jinyoung, Elizabeth Slow, Robert Chen, Andrés M. Lozano, & Alfonso Fasano. (2023). Pallidal Deep Brain Stimulation for Refractory Celiac-Related Myoclonus. Journal of Movement Disorders. 16(3). 325–327. 1 indexed citations

Taghdiri, Foad, Namita Multani, Cassandra Jessica Anor, et al.. (2020). PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers. Frontiers in Neurology. 11. 574–574. 8 indexed citations

Rajalingam, Rajasumi, David P. Breen, Robert Chen, et al.. (2019). The clinical significance of lower limb tremors. Parkinsonism & Related Disorders. 65. 165–171. 7 indexed citations

Slow, Elizabeth & Anthony E. Lang. (2019). Parkinsonism and Related Disorders. 3 indexed citations

Postuma, Ronald B., Werner Poewe, Irene Litvan, et al.. (2018). Validation of the MDS Clinical Diagnostic Criteria for Parkinson’s Disease (S3.001). Neurology. 90(15_supplement). 1 indexed citations

Zhang, Ming, Zhengrui Xi, Karen Misquitta, et al.. (2016). C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism. Movement Disorders. 32(1). 158–162. 12 indexed citations

Aquino, Camila, Elizabeth Slow, & Anthony E. Lang. (2015). Dystonic Pseudo Foot Drop. Movement Disorders Clinical Practice. 2(3). 295–298. 4 indexed citations

10.

Slow, Elizabeth, Ronald B. Postuma, & Anthony E. Lang. (2014). Implications of nocturnal symptoms towards the early diagnosis of Parkinson’s disease. Journal of Neural Transmission. 121(S1). 49–57. 12 indexed citations

11.

Graham, Rona K., Mahmoud A. Pouladi, Prasad Joshi, et al.. (2009). Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease. Journal of Neuroscience. 29(7). 2193–2204. 98 indexed citations

12.

Zhang, Hua, Qin Li, Rona K. Graham, et al.. (2008). Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Neurobiology of Disease. 31(1). 80–88. 91 indexed citations

13.

Benn, Caroline, Elizabeth Slow, Laurie Farrell, et al.. (2007). Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington’s disease. Neuroscience. 147(2). 354–372. 44 indexed citations

14.

Graham, Rona K., Yu Deng, Elizabeth Slow, et al.. (2006). Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin. Cell. 125(6). 1179–1191. 505 indexed citations breakdown →

15.

Slow, Elizabeth, Rona K. Graham, & Michael R. Hayden. (2006). To be or not to be toxic: aggregations in Huntington and Alzheimer disease. Trends in Genetics. 22(8). 408–411. 30 indexed citations

16.

Raamsdonk, Jeremy M. Van, Zoe Murphy, Elizabeth Slow, Blair R. Leavitt, & Michael R. Hayden. (2005). Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Human Molecular Genetics. 14(24). 3823–3835. 139 indexed citations

17.

Graham, Rona K., Elizabeth Slow, Yu Deng, et al.. (2005). Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models. Neurobiology of Disease. 21(2). 444–455. 69 indexed citations

18.

Raamsdonk, Jeremy M. Van, Jacqueline Pearson, Elizabeth Slow, et al.. (2005). Cognitive Dysfunction Precedes Neuropathology and Motor Abnormalities in the YAC128 Mouse Model of Huntington's Disease. Journal of Neuroscience. 25(16). 4169–4180. 252 indexed citations

19.

Slow, Elizabeth. (2003). Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Human Molecular Genetics. 12(13). 1555–1567. 640 indexed citations breakdown →

20.

Warby, Simon C., Elizabeth Slow, & Bryan Coburn. (2001). Discoveries in Charcot–Marie–Tooth disease, Crohn's disease and Bardet–Biedl syndrome 4. Clinical Genetics. 60(3). 174–176. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact